SEPN (SEPN) Stock Price & Analysis
SEPN (SEPN) rose 0.00% to USD 33.1 as of July 25, 2026 at 05:12 UTC, according to Nexqual real-time market data.
SEPN last closed at USD 33.1; the session ranged USD 32.48–34.97 on volume of 233,618 shares. Market capitalization is —, with a 52-week range of USD 10.62–38.04 (NGM). Source: Nexqual, July 25, 2026 at 05:12 UTC.
Key Statistics (as of July 25, 2026 at 05:12 UTC)
| Price | USD 33.1 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 33.1 |
| Open | USD 33.1 |
| Day Range | USD 32.48 – 34.97 |
| 52-Week Range | USD 10.62 – 38.04 |
| Volume | 233,618 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (SEPN)
Nexqual's technical model rates SEPN "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 05:12 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.95 (neutral) |
| vs SMA50 | Above (USD 32.54) |
| MACD | 0.07 (positive) |
From SEPN's Latest SEC 10-K Filing (filed 2026-03-09)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MBX | MBX Biosciences, Inc. | USD 62 | ▲ 6.35% |
| RAPP | Rapport Therapeutics, Inc. | USD 40.68 | ▼ 1.57% |
| UPB | Upstream Bio, Inc. | USD 6.41 | ▼ 2.73% |
| BCAX | Bicara Therapeutics Inc. | USD 27.02 | ▼ 3.36% |
| ALMS | Alumis Inc. | USD 28 | ▼ 2.81% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:12 UTC. This page is informational and not investment advice.